» Articles » PMID: 32707755

Cyclic Hypoxia Exposure Accelerates the Progression of Amoebic Gill Disease

Overview
Journal Pathogens
Date 2020 Jul 26
PMID 32707755
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Amoebic gill disease (AGD), caused by the amoeba , has led to considerable economic losses in every major Atlantic salmon producing country, and is increasing in frequency. The most serious infections occur during summer and autumn, when temperatures are high and poor dissolved oxygen (DO) conditions are most common. Here, we tested if exposure to cyclic hypoxia at DO saturations of 40-60% altered the course of infection with compared to normoxic controls maintained at ≥90% DO saturation. Although hypoxia exposure did not increase initial susceptibility to , it accelerated progression of the disease. By 7 days post-inoculation, amoeba counts estimated from qPCR analysis were 1.7 times higher in the hypoxic treatment than in normoxic controls, and cumulative mortalities were twice as high (16 ± 4% and 8 ± 2%), respectively. At 10 days post-inoculation, however, there were no differences between amoeba counts in the hypoxic and normoxic treatments, nor in the percentage of filaments with AGD lesions (control = 74 ± 2.8%, hypoxic = 69 ± 3.3%), or number of lamellae per lesion (control = 30 ± 0.9%, hypoxic = 27.9 ± 0.9%) as determined by histological examination. Cumulative mortalities at the termination of the experiment were similarly high in both treatments (hypoxic = 60 ± 2%, normoxic = 53 ± 11%). These results reveal that exposure to cyclic hypoxia in a diel pattern, equivalent to what salmon are exposed to in marine aquaculture cages, accelerated the progression of AGD in post-smolts.

Citing Articles

Chronic hypoxia has differential effects on constitutive and antigen-stimulated immune function in Atlantic salmon ().

Rojas I, de Mello M, Zanuzzo F, Sandrelli R, Peroni E, Hall J Front Immunol. 2025; 16:1545754.

PMID: 40046052 PMC: 11880259. DOI: 10.3389/fimmu.2025.1545754.


Dynamics of Gill Responses to a Natural Infection with in Farmed Tasmanian Atlantic Salmon.

Vallarino M, Dagen S, Costelloe E, Oyenekan S, Tinsley J, Valdenegro V Animals (Basel). 2024; 14(16).

PMID: 39199891 PMC: 11350870. DOI: 10.3390/ani14162356.


Are fish immunocompetent enough to face climate change?.

Franke A, Beemelmanns A, Miest J Biol Lett. 2024; 20(2):20230346.

PMID: 38378140 PMC: 10878809. DOI: 10.1098/rsbl.2023.0346.


Host Response of Atlantic Salmon () Re-Inoculated with .

McCormack M, Talbot A, Dillon E, OConnor I, MacCarthy E Microorganisms. 2021; 9(5).

PMID: 34062978 PMC: 8147987. DOI: 10.3390/microorganisms9050993.


Experimental Challenge Models and In Vitro Models to Investigate Efficacy of Treatments and Vaccines against Amoebic Gill Disease.

Hudson J, Nowak B Microorganisms. 2021; 9(4).

PMID: 33808191 PMC: 8065880. DOI: 10.3390/microorganisms9040710.

References
1.
Oliver E, Benthuysen J, Bindoff N, Hobday A, Holbrook N, Mundy C . The unprecedented 2015/16 Tasman Sea marine heatwave. Nat Commun. 2017; 8:16101. PMC: 5519980. DOI: 10.1038/ncomms16101. View

2.
Herrero A, K D Thompson , Ashby A, Rodger H, Dagleish M . Complex Gill Disease: an Emerging Syndrome in Farmed Atlantic Salmon (Salmo salar L.). J Comp Pathol. 2018; 163:23-28. DOI: 10.1016/j.jcpa.2018.07.004. View

3.
Hvas M, Karlsbakk E, Maehle S, Wright D, Oppedal F . The gill parasite compromises aerobic scope, swimming capacity and ion balance in Atlantic salmon. Conserv Physiol. 2017; 5(1):cox066. PMC: 5710617. DOI: 10.1093/conphys/cox066. View

4.
Lund M, Dahle M, Timmerhaus G, Alarcon M, Powell M, Aspehaug V . Hypoxia tolerance and responses to hypoxic stress during heart and skeletal muscle inflammation in Atlantic salmon (Salmo salar). PLoS One. 2017; 12(7):e0181109. PMC: 5507449. DOI: 10.1371/journal.pone.0181109. View

5.
Claireaux G, Chabot D . Responses by fishes to environmental hypoxia: integration through Fry's concept of aerobic metabolic scope. J Fish Biol. 2016; 88(1):232-51. DOI: 10.1111/jfb.12833. View